Aetna Wun Trombley

NGM is a clinical stage biopharmaceutical company advancing a robust pipeline of drug candidates to address a spectrum of large, unmet medical needs. We are focused on harnessing powerful, untapped biology underlying major diseases to develop transformative therapeutics for patients. We pair a research approach that generates novel biological insights with our expertise in protein and antibody engineering to transform those insights into breakthrough biologics product candidates. This seamless internal process seeks to address the challenges of drug discovery for diseases that involve complex, integrated biological pathways. Aimed at quickly identifying a lead candidate, our differentiated approach enables rapid advancement to and evaluation of proof-of-concept in humans.